Transfusion associated graft-versus-host disease in DiGeorge syndrome - Index case report with survey of screening procedures and use of irradiated blood components

Cardiology in the Young

Volumn 6, Issue 3, 1996, Pages 222-227

  Franklin, Rodney C G ^a   Onuzo, Obed ^a   Miller, Paul A ^a   Goldblatt, David ^b   Cummins, David ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Blood transfusion; DiGeorge syndrome; Graft versus host disease

Indexed keywords

EID: 0009505956     PISSN: 10479511     EISSN: None     Source Type: Journal    
DOI: 10.1017/s104795110000370x     Document Type: Article

References (32)

1. Brubaker DB. Human posttransfusion graft-versus-host-disease. Vox Sanguinis 1983; 45: 401-420.
2. Anderson KC, Weinstein HJ. Transfusion-associated graft-versus-host disease. New Eng J Med 1990; 323: 315-321.
3. Greenbaum BH. Transfusion-associated graft-versus-host disease: historical perspectives, incidence, and current use of irradiated blood products. J Clin Oncol 1991; 9: 1889-1902.
4. Hathaway WE, Githens JA, Blackburn JR, Fulginiti V, Kempe CH. Aplastic anaemia histiocytosis and erythroderma in immunologically deficient children. New Engl J Med 1965; 273: 953-955.
5. Parkman R, Mosier D, Umansky I, Cochran W, Carpenter CB, Rosen FS. Graft versus host disease after intra-uterine and exchange transfusions for hemolytic disease of the newborn. New Eng J Med 1974; 290: 359-363.
6. Seemayer TA, Bolande RP. Thymic involution mimicking thymic dysplasia. A consequence of transfusion induced graft versus host disease in a premature infant. Arch Path Lab Med 1980; 104: 141-144.
7. Hathaway WE, Fuginiti VA, Pierce CW, Githens JH, Pearlman DS, Muschenheim F, Kempe CH. Graft vs. host reaction following a single blood transfusion. J Am Med Assoc 1967; 201: 1015-1020.
8. Park BH, Goon RA, Gate J, Burke B. Fatal graft-versus-host reaction following transfusion of allogeneic blood and plasma in infants with combined immunodeficiency. Transplant Proc 1974; 6: 385-387.
9. Ford JM, Lucey JJ, Cullen MH, Tobias JH, Lister TA. Fatal graft-versus-host disease following transfusion of granulocytes from normal donors. Lancet 1976; ii: 1167.
10. Burns LJ, Westberg MW, Burns CF, Klassen LW, Goeken NE, Ray TL, MacFarlane DE. Acute graft versus host disease resulting from normal blood transfusion. Acta Haemat 1984; 71: 270-276.
11. Sakatibara T, Juji T. Post-transfusion graft-versus-host disease after open heart surgery. Lancet 1986; ii: 1099. [Letter]
12. Brouard J, Morin M, Borel B, Laloum D, Mandard JC, Duhamel JF, Venezia R. Graft versus host reaction complicating DiGeorge syndrome. Arch Fr Pediatr 1985; 42: 853-855.
13. Wintergerst U, Meyer U, Remberger K, Belohradsky BH. Graft-versus-host reaction in an infant with DiGeorge syndrome. Monatsschr Kinderheilkd 1989; 137: 345-347.
14. Washington K, Gossage DL, Gottfried MR. Pathology of the liver in severe combined immunodeficiency and DiGeorge syndrome. Paediatr Pathol 1993; 13: 485-504.
15. DiGeorge AM. Discussions on a new concept of the cellular basis of immunology. J Pediatr 1965; 67: 907. [Abstract]
16. Driscoll DA, Salvin J, Sellinger B, Budarf ML, McDonald-McGinn DM, Zackai EH, Emanuel BS. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J Med Genet 1993; 30: 813-817.
17. Conley ME, Beck with JB, Mancer JFK, Tenckhorff L. The spectrum of the DiGeorge syndrome. J Pediatr 1979; 94: 883-890.
18. Wilson DI, Burn J, Scambler P, Goodship J. DiGeorge syndrome: part of CATCH 22. J Med Genet 1993; 30: 852-856.
19. Muller W, Peter HH, Wilken M, Juppner H, Kallfelz HC, Krohn HP, Miller K, Rieger CHL. The DiGeorge syndrome I. Clinical evaluation and course of partial and complete forms of the syndrome. Clin Immunol Immunopathol 1988; 147: 496-502.
20. Moerman P, Dumoulin M, Lauweryns J, van der Haewaert LG. Interrupted aortic arch syndrome. Br Heart J 1987; 58: 274-278.
21. Hong R. The DiGeorge anomaly. In: Rosen FS, Seligman (eds). Immunodefiencies. Harwood Academic Publishers, 1993, pp 167-176.
22. Leitman SF, Holland PV. Irradiation of blood products. Indications and guidelines. Transfusion 1985; 25: 293-300.
23. Webb DKH. Irradiation in the prevention of transfusion associated graft-versus-host disease. Arch Dis Child 1995; 73: 388-389.
24. Dinning G, Doughty RW, Reid MM, Lloyd HL. Potassium concentrations in irradiated blood. Br Med J 1991; 303: 1110.
25. Van Mierop LHS, Kutsche LM. Cardiovascular anomalies in DiGeorge syndrome and importance of neural crest as a possible pathogenetic factor. Am J Cardiol 1986; 58: 133-137.
26. Radford DJ, Thong YH. Facial and immunological anomalies associated with tetralogy of Fallot. Int J Cardiol 1989; 22: 229-236.
27. Kiel EA, Drummond WH, Barrett DJ. Prevalence of T-lymphocyte abnormalities in infants with congenital heart disease. Am J Dis Child 1984; 138: 143-146.
28. Bastian J, Law S, Vogler L, Lawton A, Herrod H. Anderson S, Horowitz S, Hong R. Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr 1989; 115: 391-396.
29. Roethligsburger FJ, Dickson WJ. Management and the Worker. Harvard University Press, Cambridge, Massachusetts, 1939.
30. Silverman FN, Kuhn JP. Caffey's Pediatric X-ray Diagnosis: An Integrated Imaging Approach. Ninth edition. Mosby Books, St Louis, 1993, pp 651-655.
31. Yeager SB, Sanders SP. Echocardiographic identification of thymic tissue in neonates with congenital heart disease. Am Heart J 1995; 129: 837-839.
32. Hannet I, Erkeller-Yuksel F, Lydyard P, Deneys V, De Bruyère M. Developmental and maturational changes in blood lymphocyte subpopulations. Immunol Today 1992; 13: 215-218.